Antiplatelet drugs 'overused' in most patients

More than half stay on dual-antiplatelet therapy longer than recommended: Australian study

More than half of patients pres­cribed dual antiplatelet therapy for coronary artery disease remain on the drugs longer than the recommended 12 months, researchers have found in a Queensland cohort.